Ambryon Biosciences

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

Gilbert et al. (2013). Cell·Citations: 3692Research

Targeting chromatin regulators to chosen DNA sequences depended on engineering a new DNA-binding protein for each site. This work made dCas9 a modular platform, recruiting repressor or activator domains to loci set only by a coexpressed sgRNA. The repression arm became known as CRISPRi.

Key findings

  • dCas9 targeted to the tetO sites blocked rtTA-driven induction of a TetON-Venus reporter in S. cerevisiae with 115-fold repression, which suggests dCas9 can sterically compete with tightly DNA-binding transcription factors.

  • Repression by dCas9-KRAB involves no DNA cleavage. The GFP reporter locus retains a wild-type sequence with no detectable indels in knocked-down cells grown for three weeks, so dCas9 silences transcription while remaining nucleolytically inactive.

  • Stably expressed dCas9-KRAB silences a GFP reporter in HEK293 cells: six of eight sgRNAs reduce expression by at least 75%, the best about 15-fold, and remaining GFP varies linearly with sgRNA vector expression, so repression is tunable.

  • dCas9-KRAB repression is highly specific: by RNA-seq of GFP+ HEK293 cells, GFP is the only significantly suppressed transcript with an sgRNA against GFP, and no other gene changes more than 1.5-fold across two biological replicates.

  • Cotransfecting sgRNAs against CD71 and CXCR4 into HeLa cells stably expressing dCas9-KRAB silences both genes at once, and stable lentiviral expression keeps both knocked down at 7 to 8 days, so CRISPRi may be an alternate strategy to RNAi.

  • Targeting dCas9-KRAB to promoter-proximal elements silences the controlled gene: against six sgRNAs tiled across the SV40 early promoter of a GFP reporter, dCas9 alone has no effect while dCas9-KRAB represses GFP efficiently, suggesting recruitment of chromatin modifiers.

  • dCas9 represses transcription in S. cerevisiae and a fused repressor domain deepens it: against a TEF1-GFP fusion at its endogenous locus, dCas9 alone gives 18-fold repression and dCas9 fused to the Mxi1 repressor domain gives 53-fold.

Author abstract

The genetic interrogation and reprogramming of cells requires methods for robust and precise targeting of genes for expression or repression. The CRISPR-associated catalytically inactive dCas9 protein offers a general platform for RNA-guided DNA targeting. Here, we show that fusion of dCas9 to effector domains with distinct regulatory functions enables stable and efficient transcriptional repression or activation in human and yeast cells, with the site of delivery determined solely by a coexpressed short guide (sg)RNA. Coupling of dCas9 to a transcriptional repressor domain can robustly silence expression of multiple endogenous genes. RNA-seq analysis indicates that CRISPR interference (CRISPRi)-mediated transcriptional repression is highly specific. Our results establish that the CRISPR system can be used as a modular and flexible DNA-binding platform for the recruitment of proteins to a target DNA sequence, revealing the potential of CRISPRi as a general tool for the precise regulation of gene expression in eukaryotic cells.

Identifiers & revision